IP Library Granted Patent US 11,041,203
Granted Patent B2
US 11,041,203 · App. 14/512,682 · Granted Jun 22, 2021

Methods for assessing a genomic region of a subject

Inventors: Mark Umbarger (Brookline, MA); Gregory Porreca (Cambridge, MA)
Assignee: Molecular Loop Biosolutions, Inc.
C12Q1/6883C12Q2600/156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,041,203
App. No.
14/512,682
Granted
Jun 22, 2021
Kind
B2
Abstract

The invention generally relates to method for assessing a genomic region of a subject. In certain embodiments, methods of the invention involve obtaining a sample including nucleic acid from a subject. The nucleic acid includes a target sequence from a target genomic region and a paralogous sequence from a non-target genomic region. The target sequence and the paralogous sequence are isolated from the sample. The target sequence and the paralogous sequence are sequenced to obtain sequence reads that include target sequence reads and paralogous sequence reads. The paralogous sequence reads are excluded, and the genomic region of the subject are assessed based on the target sequence reads.

Claims (47)

1. A method for assessing a genomic region of a subject, the method comprising:

obtaining a sample comprising nucleic acid from a subject, the nucleic acid comprising a target sequence from a target genomic region and a paralogous sequence from a non-target genomic region;

isolating the target sequence and the paralogous sequence from the sample;

sequencing the target sequence and the paralogous seqeunce to obtain sequence reads that comprise target sequence reads and paralogous sequence reads;

excluding the paralogous sequence reads, wherein excluding comprises:

creating a training set of target sequence reads, wherein the training set is created by:

amplifying of nucleic acids using target-specific primers;

sequencing of resulting amplicons;

identification of variants in amplicon sequences; and

defining the training set as comprising the identified variants;

identifying one or more variants observed in the sequence reads that are not present in the training set of target sequence reads as being of paralogous origin;

calculating a frequency of sequence reads comprising variants identified as being of paralogous origin;

defining variant paralogous sequence reads to be excluded based on their calculated frequency; and

excluding the defined variant paralogous sequence reads; and

assembling and aligning target sequence reads that exclude paralogous sequence reads, based on their frequency, to assess the genomic region of the subject based on the target sequence reads.

2. The method according to claim 1 , wherein isolating comprises conducting an assay that uses molecular inversion probes.

3. The method according to claim 2 , wherein the assay comprises:

hybridizing said molecular inversion probes to the target sequence the paralogous sequence;

circularizing the hybridized probes;

isolating the circularized probes; and

linearizing the circularized probes.

4. The method according to claim 1 , wherein sequencing is sequencing by synthesis.

5. The method according to claim 1 , wherein the sample is a human body fluid sample.

6. The method according to claim 3 , wherein sequencing by synthesis is single molecule sequencing by synthesis.

7. The method according to claim 5 , wherein the sample is a maternal blood sample.

8. The method according to claim 7 , wherein the maternal blood sample comprises cell free circulating nucleic acid.

9. The method according to claim 8 , wherein at least a portion of the cell free circulating nucleic acid is from a fetus being carried the subject.

10. The method according to claim 1 , wherein the sample is a human body fluid sample.

11. The method according to claim 10 , wherein the body fluid sample comprises cell free circulating nucleic acid.

12. The method according to claim 10 , wherein the sample is a maternal blood sample.

13. The method according to claim 12 , wherein the maternal blood sample comprises cell free circulating nucleic acid.

14. The method according to claim 13 , wherein at least a portion of the cell free circulating nucleic acid is from a fetus being carried the subject.

15. A method for assessing a genomic region of a subject, the method comprising:

obtaining sequence reads that comprise target sequence reads and paralogous sequence reads;

excluding the paralogous sequence reads, wherein excluding comprises:

creating a training set of target sequence reads, wherein the training set is created by:

amplifying nucleic acids using target-specific primers;

sequencing of resulting amplicons;

identification of variants in amplicon sequences; and

defining the training set as comprising the identified variants;

identifying one or more variants observed in the sequence reads that are not present in the training set of target sequence reads as being of paralogous origin;

calculating a frequency of sequence reads comprising variants identified as being of paralogous origin;

defining variant paralogous sequence reads to be excluded based on their calculated frequency; and

excluding the defined variant paralogous sequence reads; and

assembling and aligning target sequence reads that exclude paralogous sequence reads, based on their frequency, to assess a genomic region of a subject based on the target sequence reads.

16. The method according to claim 15 , wherein sequencing by is sequencing by synthesis.

17. The method according to claim 16 , wherein sequencing by synthesis is single molecule sequencing by synthesis.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 25, 2025
From: MOLECULAR LOOP BIOSCIENCES, INC.
To: MOLECULAR LOOP INNOVATIONS LLC
Reel/Frame 070326/0558 →
CHANGE OF NAME Recorded May 20, 2021
From: MOLECULAR LOOP BIOSOLUTIONS, LLC
To: MOLECULAR LOOP BIOSCIENCES, INC.
Reel/Frame 056302/0277 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 9, 2018
From: GOOD START GENETICS, INC.
To: MOLECULAR LOOP BIOSOLUTIONS, LLC
Reel/Frame 047459/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 27, 2015
From: UMBARGER, MARK; PORRECA, GREGORY
To: GOOD START GENETICS, INC.
Reel/Frame 035498/0332 →